D.E. Shaw & Co’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-581,446
| Closed | -$1.85M | – | 5817 |
|
|
2022
Q2 | $1.85M | Sell |
581,446
-18,624
| -3% | -$72.5K | ﹤0.01% | 3141 |
|
|
2022
Q1 | $2.56M | Buy |
600,070
+11,268
| +2% | +$49.1K | ﹤0.01% | 3059 |
|
|
2021
Q4 | $2.74M | Sell |
588,802
-21,852
| -4% | -$91.1K | ﹤0.01% | 3062 |
|
|
2021
Q3 | $2.44M | Sell |
610,654
-36,874
| -6% | -$146K | ﹤0.01% | 2849 |
|
|
2021
Q2 | $2.77M | Sell |
647,528
-83,609
| -11% | -$358K | ﹤0.01% | 2605 |
|
|
2021
Q1 | $3.1M | Buy |
731,137
+315,401
| +76% | +$1.74M | ﹤0.01% | 2210 |
|
|
2020
Q4 | $1.61M | Buy |
415,736
+185,639
| +81% | +$793K | ﹤0.01% | 2693 |
|
|
2020
Q3 | $927K | Buy |
+230,097
| New | +$953K | ﹤0.01% | 2912 |
|
|
2020
Q1 | – | Sell |
-73,167
| Closed | -$288K | – | 4497 |
|
|
2019
Q4 | $288K | Sell |
73,167
-190,702
| -72% | -$1.13M | ﹤0.01% | 3646 |
|
|
2019
Q3 | $2.32M | Buy |
263,869
+112,429
| +74% | +$1.06M | ﹤0.01% | 2245 |
|
|
2019
Q2 | $1.4M | Sell |
151,440
-437,181
| -74% | -$3.29M | ﹤0.01% | 2476 |
|
|
2019
Q1 | $3.79M | Buy |
+588,621
| New | +$3.83M | ﹤0.01% | 1731 |
|
|
2017
Q4 | – | Sell |
-128,184
| Closed | -$4.46M | – | 3938 |
|
|
2017
Q3 | $4.46M | Buy |
128,184
+65,504
| +105% | +$2.11M | 0.01% | 1460 |
|
|
2017
Q2 | $1.87M | Sell |
62,680
-124,478
| -67% | -$3.57M | ﹤0.01% | 2019 |
|
|
2017
Q1 | $5.59M | Buy |
+187,158
| New | +$4.78M | 0.01% | 1219 |
|
|
2015
Q4 | – | Sell |
-9,072
| Closed | -$252K | – | 4162 |
|
|
2015
Q3 | $252K | Sell |
9,072
-84,563
| -90% | -$2.66M | ﹤0.01% | 3411 |
|
|
2015
Q2 | $2.29M | Sell |
93,635
-72,479
| -44% | -$1.49M | ﹤0.01% | 2080 |
|
|
2015
Q1 | $3.04M | Buy |
166,114
+100,236
| +152% | +$2.03M | ﹤0.01% | 1723 |
|
|
2014
Q4 | $1.22M | Buy |
+65,878
| New | +$782K | ﹤0.01% | 2674 |
|
D.E. Shaw & Co's LJPC Position: Q3 2022 in Review
D.E. Shaw & Co sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 581,446 shares — an estimated $1.85M sold.
D.E. Shaw & Co first reported a position in LJPC in Q4 2014 and held it in 19 quarters. The position peaked at $5.59M in Q1 2017. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.
- D.E. Shaw & Co reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
- D.E. Shaw & Co sold 581,446 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $1.85M.
- D.E. Shaw & Co first reported a position in La Jolla Pharmaceutical Company in Q4 2014 and held it in 19 quarters.
- D.E. Shaw & Co's La Jolla Pharmaceutical Company position peaked at $5.59M in Q1 2017.
- 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.